HCM
MRNA icon

Howard Capital Management’s Moderna MRNA Stock Holding History

Howard Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,994
Closed -$416K – 399
2024
Q4 		$416K Buy
9,994
+297
+3% +$14.2K 0.01% 309
2024
Q3 		$648K Buy
+9,697
New +$890K 0.01% 255

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Howard Capital Management's MRNA Position: Q1 2025 in Review

Howard Capital Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 9,994 shares — an estimated $416K sold.

Howard Capital Management first reported a position in MRNA in Q3 2024 and held it in 2 quarters. The position peaked at $648K in Q3 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Howard Capital Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Howard Capital Management sold 9,994 Moderna shares in Q1 2025, an estimated $416K.
  • Howard Capital Management first reported a position in Moderna in Q3 2024 and held it in 2 quarters.
  • Howard Capital Management's Moderna position peaked at $648K in Q3 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Howard Capital Management's 13F filing for Q1 2025, filed 8 May 2025.